Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative waiting time, anxiety, and recovery in percutaneous nephrolithotomy with remimazolam and TEAS
ChiCTR2400080804Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and propofol in nephrolithiasis (3 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Postoperative recovery status, Preoperative anxiety and depression and 2 more. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on ChiCTR2400080804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080804.